JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $76,565 | $66,311 | $83,627 | $88,603 |
| - Cash | $106 | $13,180 | $13,196 | $15,513 |
| + Debt | $271 | $40,105 | $38,105 | $32,392 |
| Enterprise Value | $76,731 | $93,236 | $108,536 | $105,482 |
| Revenue | $86 | $59 | $7,192 | $9,223 |
| % Growth | 45.4% | -99.2% | -22% | – |
| Gross Profit | $73 | $43 | $2,866 | $6,546 |
| % Margin | 84.3% | 72.1% | 39.8% | 71% |
| EBITDA | $28 | $200 | -$5,101 | $739 |
| % Margin | 32% | 335.5% | -70.9% | 8% |
| Net Income | $15 | -$546 | -$4,183 | $115 |
| % Margin | 17.6% | -918.3% | -58.2% | 1.2% |
| EPS Diluted | 0.13 | -4.48 | -34.28 | 0.93 |
| % Growth | 102.9% | 86.9% | -3,786% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |